
About Aptus Pharmaceuticals
Aptus Pharmaceuticals is a company based in Gaithersburg (United States) founded in 2010. Limited information available. Aptus Pharmaceuticals has raised $6.2 million across 1 funding round from investors including Vital Bio Systems, Emerging Technology Partners and ROMA99. The company has 28 employees. Its Indian entity Aptus Pharma Limited reported revenue of βΉ46.70 Cr. Aptus Pharmaceuticals offers products and services including Pharmaceutical Products and Export Services.
Company details
Aptus Pharmaceuticals was founded in 2010 and is located in Gaithersburg, United States. Operations are centered in the pharmaceutical sector, where drug discovery and formulation activities are undertaken. Research efforts are directed toward therapeutic solutions, with manufacturing processes handled domestically. The company maintains a presence through its domain aptuspharma.com, serving the healthcare industry in the region.
- Headquarters Gaithersburg, United States
- Employees 28
- Website aptuspharma.com
- Legal Name Aptus Pharma Ltd.
- Date of Incorporation 12 Aug, 2010
- Jurisdiction Ahmedabad, Gujarat, India
- Indian entity revenue₹46.70 Cr
FY 2026 · +90% YoY
- Indian entity net profit₹4.60 Cr
FY 2026 · 10% margin
- Indian entity EBITDA₹7.43 Cr
FY 2026 · 16% margin
- Total Equity Funding$6.2M (USD)
in 1 rounds
- Latest Funding Round$6.2M (USD), Series A
May 2011
- InvestorsVital Bio Systems
& 2 more
- Employee Count28
Associated legal entities of Aptus Pharmaceuticals
Aptus Pharmaceuticals operates through Aptus Pharma Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aptus Pharma Limited Listed CIN U24230GJ2010PLC061957 | Active | 12 Aug 2010 | Ahmedabad, Gujarat | ₹46.7 Cr | 28 | 9 | View details |
Products & Services of Aptus Pharmaceuticals
Aptus Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Export Services.
Pharmaceutical drugs are manufactured and sold for healthcare purposes, with compliance to international standards being maintained.
International export of pharmaceutical products is handled through a dedicated division, as expansion plans are outlined in the company's profile.
Funding Insights of Aptus Pharmaceuticals
Aptus Pharmaceuticals has successfully raised a total of $6.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.2 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.2M
- Total Rounds 1
- Last Round Series A β $6.2M
- First Round $6.2M
(May 2011)
- Investors Count 3
All 1 funding rounds of Aptus Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2011 | $6.2M | Series A | β | β |
3 investors in total: 3 institutional.
Investors in Aptus Pharmaceuticals
Aptus Pharmaceuticals has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Vital Bio Systems, Emerging Technology Partners and ROMA99.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
ROMA99 is recognized as a trusted online gaming platform. | grosvenorfund.com | |||
| etpventures.com | ||||
Manufacturing and distributing medical equipment for healthcare specialists in India. | 1991 | vitalbiosystems.com | Chennai, India |
Investor details for Aptus Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aptus Pharma Limited (Aptus Pharmaceuticals)
Aptus Pharma Limited is the primary company behind Aptus Pharmaceuticals. The board of Aptus Pharma Limited currently have 6 directors; the longest-serving is Tejash Maheshchandra Hathi, appointed in 2010. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejash Maheshchandra Hathi DIN 03151221 | Managing Director | 12 Aug 2010 | 16 yrs 3 mo | Aptus Pharma Limited |
| Chetan Shantilal Lalseta DIN 02547012 | Director | 17 Jan 2024 | 2 yrs 10 mo | Aptus Pharma Limited |
| Riddhish Natwarlal Tanna DIN 03231612 | Director | 17 Jan 2024 | 2 yrs 10 mo | Aptus Pharma Limited |
| Jyotiben Hasmukhbhai Chandarana DIN 10607059 | Director | 20 May 2024 | 2 yrs 6 mo | Aptus Pharma Limited |
| Sejal Harit Palan DIN 10893463 | Director | 06 Feb 2025 | 1 yr 9 mo | Aptus Pharma Limited |
| Vikas Rambhai Jobanputra DIN 10921323 | Director | 06 Feb 2025 | 1 yr 9 mo | Aptus Pharma Limited |
Financials of Aptus Pharmaceuticals
Figures of Aptus Pharma Limited, the primary company behind Aptus Pharmaceuticals, for FY 2026. Revenue was ₹46.70 Cr (+90% year on year). Net profit was ₹4.60 Cr (10% margin). EBITDA was ₹7.43 Cr (16% margin). Revenue has grown at a compounded annual rate of +50% over three years.
- ₹46.70 CrRevenue · FY 2026 · +90% YoY
- ₹4.60 CrNet profit · 10% margin
- ₹7.43 CrEBITDA · 16% margin
- ₹6.86 CrPaid-up capital
- 28Employees (provident fund records)
- +50%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Aptus Pharma Limited are on its company page.
Detailed financial statements for Aptus Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Aptus Pharmaceuticals
2 dated milestones of Aptus Pharmaceuticals across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Aptus Pharmaceuticals is founded.
- Funding First funding round of $6.2M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aptus Pharmaceuticals
Complete news archive for Aptus Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptus Pharmaceuticals
Aptus Pharmaceuticals was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Aptus Pharmaceuticals is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Aptus Pharmaceuticals is a funded company, having raised a total of $6.2M across 1 funding round to date. The company's 1st funding round was a Series A of $6.2M, raised on May 2011.
Aptus Pharmaceuticals has 28 employees.
The primary company behind Aptus Pharmaceuticals, Aptus Pharma Limited, reported revenue of βΉ46.70 Cr for FY 2026, up 90% year on year.
Aptus Pharmaceuticals was founded in 2010 and is located in Gaithersburg, United States. Operations are centered in the pharmaceutical sector, where drug discovery and formulation activities are undertaken. Research efforts are directed toward therapeutic solutions, with manufacturing processes handled domestically. The company maintains a presence through its domain aptuspharma.com, serving the healthcare industry in the region.
Aptus Pharmaceuticals offers Pharmaceutical Products and Export Services.
Aptus Pharmaceuticals has 3 investors. Key investors include Vital Bio Systems, Emerging Technology Partners, and ROMA99.
Aptus Pharmaceuticals operates through Aptus Pharma Limited.
The legal entities of Aptus Pharmaceuticals currently have 9 directors, including Ghanshyam Vinubhai Pansuriya, Kapilbhai Hasmukhbhai Chandarana, Tejash Maheshchandra Hathi and others.
